Further evidence for the role of adenosine in hypercapnia/acidosis-evoked coronary flow regulation

Citation
Jw. Phillis et al., Further evidence for the role of adenosine in hypercapnia/acidosis-evoked coronary flow regulation, GEN PHARM, 33(5), 1999, pp. 431-437
Citations number
44
Categorie Soggetti
Pharmacology & Toxicology
Journal title
GENERAL PHARMACOLOGY
ISSN journal
03063623 → ACNP
Volume
33
Issue
5
Year of publication
1999
Pages
431 - 437
Database
ISI
SICI code
0306-3623(199911)33:5<431:FEFTRO>2.0.ZU;2-R
Abstract
Experiments were performed on isolated, nonworking rat hearts perfused at c onstant pressure according to the Langendorff technique to evaluate the rol e of adenosine in hypercapnia-evoked coronary vasodilation. Hypercapnia/aci dosios resulted in increases in heart rate and coronary flow rates in conju nction with a decrease in ventricular contractile tensions. The adenosine d eaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA, 10 mu M) re duced the heart rate and enhanced CO2-evoked increases in coronary vascular flow. 5-Iodotubercidin (1 mu M), an inhibitor of adenosine kinase, caused a reduction in heart rate and enhanced coronary flow rates during hypercapn ic perfusion. Adenosine deaminase (1 U/ml) significantly attenuated CO2-evo ked increases in coronary vascular flow. These results extend those of prev ious investigations implicating adenosine in the regulation of coronary flo w during conditions of respiratory or metabolic acidosis. (C) 1999 Elsevier Science Inc. All rights reserved.